If you're switching because current drug stopped working or isn't producing enough weight loss, you'll likely want to land at a dose on new drug that matches or exceeds what you were on
for semaglutide (Wegovy), evaluate response once maintenance dose is reached Six-monthly reviews thereafter, including liver function tests, renal function, and metabolic parameters Annual comprehensive review including cardiovascular risk assessment NAFLD monitoring may include repeat FIB-4 or ELF testing
The key distinction: purging happens in your typical problem areas and resolves within four to eight weeks of consistent use
It diminishes adipocytes and promotes collagen production, improving skin elasticity
Lifestyle modification, nutrition, and mindset shift are essential for maintaining improvements, independent of medication